A Phase 3, Multi Centre, Open label, Parallel, Two Groups, Multi Arm, Randomized, Registration Clinical Study to Evaluate the Efficacy and Safety of Colesevelam Hydrochloride as Combination Therapy in Adult Indian Non Diabetic Patients with Primary Hyperlipidemia and Type II Diabetic Patients with Primary Hyperlipidemia

Trial Profile

A Phase 3, Multi Centre, Open label, Parallel, Two Groups, Multi Arm, Randomized, Registration Clinical Study to Evaluate the Efficacy and Safety of Colesevelam Hydrochloride as Combination Therapy in Adult Indian Non Diabetic Patients with Primary Hyperlipidemia and Type II Diabetic Patients with Primary Hyperlipidemia

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Colesevelam (Primary) ; HMG-CoA reductase inhibitors; Metformin
  • Indications Hyperlipidaemia; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top